Osteoprotegerin ligand regulates osteoclast adherence to the bone surface in mouse calvaria

Biochemical and Biophysical Research Communications

Volumn 274, Issue 2, 2000, Pages 281-290

  O'Brien, E A ^a,b   Williams, J H H ^b   Marshall, M J ^a  

^a ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CHESTER   (United Kingdom)

Author keywords

Adhesion; Alpha v beta 3 integrin; Osteoprotegerin; Osteoprotegerin ligand; Prostaglandin

Indexed keywords

CALCITRIOL; INTEGRIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROSTAGLANDIN E2; RECOMBINANT PROTEIN;

ANIMAL TISSUE; ARTICLE; BONE; CALVARIA; CELL ADHESION; CONTROLLED STUDY; GENE INDUCTION; HUMAN; MOUSE; NONHUMAN; OSTEOCLAST; PERIOSTEUM; PRIORITY JOURNAL;

ANIMALIA;

EID: 0034596229     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3129     Document Type: Article

References (31)

1. Ash P., Loutit J. F., Townsend K. M. S. Osteoclasts derived from haematopoietic stem cells. Nature. 283:1980;669-670.
2. Gothlin G., Ericsson J. The osteoclast. Clin. Orthoped. Rel. Res. 120:1976;201-231.
3. Kurihara N., Chenu C., Miller M., Civin C., Roodman G. D. Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures. Endocrinology. 126:1990;2733-2741.
4. Kerby J. A., Hattersley G., Collins D. A., Chambers T. J. Derivation of osteoclasts from hematopoietic colony-forming cells in culture. J. Bone Miner. Res. 7:1992;353-358.
5. 2 production in osteoblasts. Calcif. Tissue Int. 52:1993;62-66.
6. Helfrich M. H., Nesbitt S. A., Dorey E. L., Horton M. A. Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins including the bone sialoproteins and fibronectin, via a β3 integrin. J. Bone Miner. Res. 7:1992;35-343.
7. Rodan S. B., Rodan G. A. Integrin function in osteoclasts. J. Endocrinol. 154:1997;S47-S56.
8. Holt I., Marshall M. J. Integrin subunit β3 plays a crucial role in the movement of osteoclasts from the periosteum to the bone surface. J. Cell Physiol. 175:1998;9.
9. Nakamura I., Gailit J., Sasaki T. Osteoclast integrin αvβ3 is present in the clear zone and contributes to cellular polarization. Cell Tissue Res. 286:1996;507-515.
10. McSheehy P. M. J., Chambers T. J. Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology. 119:1986;1654-1659.
11. Thomson B. M., Saklatvala J., Chambers T. J. Osteoblasts mediate interleukin-1 stimulation of bone resorption by rat osteoclasts. J. Exp. Med. 164:1986;104-112.
12. 3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption. J. Clin. Invest. 80:1987;425-429.
13. 2 initially inhibits and then stimulates bone resorption in isolated rabbit osteoclast cultures. Bone Miner. 7:1989;255-266.
14. Suda T., Udagawa N., Nakamura I., Miyaura C., Takahashi N. Modulation of osteoclast differentiation by local factors. Bone. 17:1995;87S-91S.
15. Lacey D. L., Timms E., Tan H. L., Kelley M. J., Dunstan C. R., Burgess T., Elliot R., Colombero A., Elliot G., Scully S., Hsu H., Sullivan J., Hawkins N., Davy E., Capparelli C., Eli A., Qian Y.-X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Guo J., Delaney J., Boyle W. J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:1998;165-176.
16. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashio K., Udagawa N., Takahashi N., Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA. 95:1998;3597-3602.
17. 2, or parathyroid hormone in the microenvironment of bone. Biochem. Biophys. Res. Commun. 246:1998;337-341.
18. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Goto M., Mochizuki S.-I., Tsuda E., Morinaga T., Udagawa N., Takahashi N., Suda T., Higashio K. A novel molecular mechanism modulating osteoclast differentiation and function. Bone. 25:1999;109-113.
19. Tsuda E., Goto M., Mochizuki S., Yano K., Kobayashi F., Morinaga T., Higashio K. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem. Biophys. Res. Commun. 234:1997;137-142.
20. Simonet W. S., Lacey D. L., Dunstan C. R., Kelley M., Chang M. S., Luthy R., Nguyen H. Q., Wooden S., Bennett L., Boone T., Shimamoto G., DeRose M., Elliot R., Colombero A., Tan H.-L., Trail G., Sullivan J., Davy E., Bucay N., Renshaw-Gegg L., Hughes T. M., Hill D., Pattison W., Campbell P., Sander S., Van G., Tarpley J., Derby P., Lee R., Boyle W. J. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell. 89:1997;309-319.
21. 3. J. Bone Miner. Res. 14:1999;1478-1485.
22. Holt I., Davie M. W. J., Braidman I. P., Marshall M. J. Prostaglandin E2 stimulates the production of interleukin-6 by neonatal mouse parietal bones. Bone Miner. 5:1994;47-57.
23. Lerner U. H. Modification of the mouse calvarial technique improves responsiveness to stimulators of bone resorption. J. Bone Miner. Res. 2:1987;375-383.
24. Marshall M. J., Holt I., Davie M. W. J. Inhibition of prostaglandin synthesis leads to a change in adherence of mouse osteoclasts from bone to periosteum. Calcif. Tissue Int. 59:1996;207-213.
25. 3. Calcif. Tissue Int. 56:1995;240-245.
26. Garrett I. R., Mundy G. R. Relationship between interleukin-1 and prostaglandins in resorbing neonatal calvaria. J. Bone Miner. Res. 4:1989;789-794.
27. Horton M. A., Taylor M. L., Arnett T. R., Helfrich M. H. Arg-Gly-Asp (RGD) peptides and the antivitronectin receptor anti-body 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp. Cell Res. 195:1991;368-375.
28. Crippes B. A., Engelman V. W., Settle S. L., Delarco J., Ornberg R. L., Helfrich M. H., Horton M. A., Nickols G. A. Antibody to β3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat. Endocrinology. 137:1996;918-924.
29. Sato M., Garsky V., Majeska R., Einhorn T., Murray J., Tashjian A., Gould R. Structure-activity studies of the s-echistatin inhibition of bone resorption. J. Bone Miner. Res. 9:1994;1441-1449.
30. 2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: Synergistic activation of differentiation, cell spreading and fusion. Endocrinology. 140:1999;1927-1935.
31. Horwood N. J., Elliot J., Martin T. J., Gillespie M. T. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology. 139:1998;4743-4746.